In addition, METTL3 was also reported to promote resistance to chemotherapy, including GEM, 5-fluorouracil, cisplatin, and radiotherapy of pancreatic cancer cells [9]. This evidence concerns the gene METTL3 and familial pancreatic carcinoma.